Risk Factors for the Development of High-risk Stigmata in Branch-duct Intraductal Papillary Mucinous Neoplasms
Open Access
- 15 October 2021
- journal article
- research article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 60 (20), 3205-3211
- https://doi.org/10.2169/internalmedicine.7168-21
Abstract
Objective Strict follow-up is recommended for branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) to avoid missing the development of high-risk stigmata (HRS) at a premalignant stage. This study explored the risk factors associated with the development of HRS during follow-up. Methods We performed a retrospective analysis of 283 patients with BD-IPMN, treated at Okayama University Hospital in Japan between January 2009 and December 2016. Only patients with imaging studies indicative of classical features of BD-IPMN without HRS and followed for over one year were included in the study. We performed radiological follow-up every six months and collected patients' demographic data, cyst characteristics, and clinical outcomes and used univariate logistic regression models to determine the odds of developing HRS. Results Ten patients (3.5%) developed HRS after a median surveillance period of 55.8 months. The main pancreatic duct (MPD) size (5-9 mm) and cyst growth rate (>2.5 mm/year) were both suggested to be possible risk factors for the development of HRS (odds ratio, 14.2; 95% confidence interval [CI], 3.1-65.2, p=0.0006, and odds ratio, 6.1; 95% CI 1.5-25.5, p=0.014). Regarding the number of worrisome features (WFs), the rate of HRS development was 2.0% (4/199) in cases with no WF, 1.6% (1/62) in cases with single WF and 22.7% (5/22) in cases with multiple WFs, respectively. The rate of HRS development was significantly higher in cases with multiple WFs than in the other cases (p<0.0001). Conclusion MPD dilation, rapid cyst growth, and multiple WFs were significant risk factors for the development of HRS. In the presence of such features, it is necessary to closely follow the development of HRS and avoid missing the best opportunity to perform surgical intervention.Keywords
This publication has 22 references indexed in Scilit:
- Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance ImagingAnnals of Surgery, 2016
- American Gastroenterological Association Institute Guideline on the Diagnosis and Management of Asymptomatic Neoplastic Pancreatic CystsGastroenterology, 2015
- “High-Risk Stigmata” of the 2012 International Consensus Guidelines Correlate With the Malignant Grade of Branch Duct Intraductal Papillary Mucinous Neoplasms of the PancreasPancreas, 2014
- Cyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Meta-AnalysisClinical Gastroenterology and Hepatology, 2013
- The Clinical Relevance of the Increasing Incidence of Intraductal Papillary Mucinous NeoplasmClinical Gastroenterology and Hepatology, 2012
- The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreasPancreatology, 2012
- Cyst Growth Rate Predicts Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous NeoplasmsClinical Gastroenterology and Hepatology, 2011
- Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings CommitteeJournal of the American College of Radiology, 2010
- Natural History of Intraductal Papillary Mucinous Neoplasms (IPMN): Current Evidence and Implications for ManagementJournal of Gastrointestinal Surgery, 2008
- Pancreatic Cysts: Depiction on Single-Shot Fast Spin-Echo MR ImagesRadiology, 2002